The level of TNF soluble receptor type 1 in patients with systemic sclerosis

The level of TNF soluble receptor type 1 in patients with systemic sclerosis

Aim. To study content and clinical correlations ofsTNF-RI in patients with systemic sclerosis (SS). Material and methods. Thirty nine SS patients were examined with enzyme immunoassay for serum levels of sTNF-RIand soluble adhesion molecules (sSAM) sVSAM-1, sISAM-1 and sR-selectine using R&D Sys...

Full description

Bibliographic Details
Main Authors:	R Т Alekperov, A V Timchenko, M Yu Samsonov, N G Guseva, E L Nasonov
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2004-05-01
Series:	Терапевтический архив
Subjects:	systemic sclerosis tnf-ri
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/29786

Similar Items

Changes in Cerebrospinal Fluid Balance of TNF and TNF Receptors in Naïve Multiple Sclerosis Patients: Early Involvement in Compartmentalised Intrathecal Inflammation
by: Roberta Magliozzi, et al.
Published: (2021-07-01)

Co-expression of TNF receptors 1 and 2 on melanomas facilitates soluble TNF-induced resistance to MAPK pathway inhibitors
by: Cindy A. Sander, et al.
Published: (2022-07-01)

Coexistence of Ankylosing Spondylitis and Multiple Sclerosis: Trigger with TNF-alpha Antagonist Therapy or Coincidental?
by: Bahar Say, et al.
Published: (2019-09-01)

Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis
by: Roberta Magliozzi, et al.
Published: (2019-12-01)

Lansap in treatment of esophagitis in patients with systemic sclerosis
by: R T Alekperov, et al.
Published: (2003-04-01)

IL-6 and TNF-α responses to acute and regular exercise in adult individuals with multiple sclerosis (MS): a systematic review and meta-analysis
by: Parnian Shobeiri, et al.
Published: (2022-09-01)

An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis
by: Alexander Vugler, et al.
Published: (2022-11-01)

TWEAK and TNFα, Both TNF Ligand Family Members and Multiple Sclerosis-Related Cytokines, Induce Distinct Gene Response in Human Brain Microvascular Endothelial Cells
by: Delphine Stephan, et al.
Published: (2022-09-01)

Serum concentrations of TNF-α and its soluble receptors in Graves’ disease
by: Qing Zhu, et al.
Published: (2020-08-01)

Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents
by: Huimin Zou, et al.
Published: (2018-03-01)

Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes
by: Richard J MacIsaac, et al.
Published: (2019-11-01)

Receptor Specificity Engineering of TNF Superfamily Ligands
by: Fengzhi Suo, et al.
Published: (2022-01-01)

Antibody-Mediated Porcine Reproductive and Respiratory Syndrome Virus Infection Downregulates the Production of Interferon-α and Tumor Necrosis Factor-α in Porcine Alveolar Macrophages via Fc Gamma Receptor I and III
by: Liujun Zhang, et al.
Published: (2020-02-01)

Serial measurement of the circulating levels of tumour necrosis factor and its soluble receptors 1 and 2 for monitoring leprosy patients during multidrug treatment
by: Rosane Dias Costa, et al.
Published: (2013-12-01)

Reconciling intrinsic properties of activating TNF receptors by native ligands versus synthetic agonists
by: George Fromm, et al.
Published: (2023-09-01)

TNF RECEPTOR 2 AND DISEASE: Autoimmunity and Regenerative Medicine
by: Denise Louise Faustman, et al.
Published: (2013-12-01)

Immune Profiling of Patients with Systemic Sclerosis through Targeted Proteomic Analysis
by: Iulia Szabo, et al.
Published: (2023-12-01)

Relationship between Dynamics of TNF-α and Its Soluble Receptors in Saliva and Periodontal Health State
by: Ryota Kibune, et al.
Published: (2022-02-01)

Adaptive Features of Natural Killer Cells in Multiple Sclerosis
by: Antía Moreira, et al.
Published: (2019-10-01)

First Case of TNF-Receptor-Associated Autoinflammatory Syndrome (TRAPS) in Bulgaria
by: Solakov Panayot T.
Published: (2016-09-01)

Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active toxoplasmic retinochoroiditis
by: Thais Fontes Bessa, et al.
Published: (2012-12-01)

Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active toxoplasmic retinochoroiditis
by: Thais Fontes Bessa, et al.

CLINICAL ASSOCIATIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS TYPE 2 RECEPTOR IN SYSTEMIC SCLEROSIS
by: R. T. Alekperov, et al.
Published: (2018-11-01)

The benefits of clustering in TNF receptor superfamily signaling
by: Éva S. Vanamee, et al.
Published: (2023-08-01)

Ankylosing spondylitis and multiple sclerosis: a surprising parallel
by: Iulia Georgiana Stamate, et al.
Published: (2014-09-01)

Elevated Soluble TNF-Receptor 1 in the Serum of Predementia Subjects with Cerebral Small Vessel Disease
by: Kaung H. T. Salai, et al.
Published: (2023-03-01)

Circulating Levels of Adipokines and TNF in Patients with and without Type 1 Diabetes
by: Anila Jaleel, et al.
Published: (2013-01-01)

Glucocorticoids Regulate the Vascular Remodeling of Aortic Dissection Via the p38 MAPK-HSP27 Pathway Mediated by Soluble TNF-RII
by: Lei Zhang, et al.
Published: (2018-01-01)

Eosinophil recruitment in TNF-receptor-deficient mice
by: Shepherd Malcolm, et al.
Published: (2001-06-01)

Behҫet’s Disease, and the Role of TNF-α and TNF-α Blockers
by: Tim van der Houwen, et al.
Published: (2020-04-01)

Tumor necrosis factor superfamily in multiple sclerosis: from pathology to therapeutic implications
by: Federica Azzolini, et al.
Published: (2023-05-01)

SYSTEMIC SCLEROSIS AND OSTEOPOROSIS
by: R. T. Alekperov, et al.
Published: (2016-02-01)

Juridical Overview of the Position of the Regional Representative Council (DPD) of the Republic of Indonesia in the Legislation System in Indonesia
by: David Aprizon Putra
Published: (2022-06-01)

Exogenous soluble tumor necrosis factor receptor type I ameliorates murine experimental autoimmune neuritis
by: Lei Bao, et al.
Published: (2003-02-01)

TUMOR NECROSIS FACTOR-α MEMBRANE-BOUND AND SOLUBLE RECEPTORS IN NORM AND IN RHEUMATOID ARTHRITIS
by: A. A. Alshevskaya, et al.
Published: (2012-05-01)

LEVELS OF TNF-α IN ASYMPTOMATIC APICAL PERIODONTITIS
by: Teodora Karteva, et al.
Published: (2019-12-01)

Reconstrucción de ligamento cruzado anterior con isquiotibiales manteniendo su inserción tibial
by: Sergio Andrés Sandrigo, et al.
Published: (2024-02-01)

Evaluation of FcεRI-Bindable Human Ige With an Enzyme-Linked Immunosorbent Assay Using a Recombinant Soluble form of the Human FcεRIα Ectodomain
by: Naruhito Wada, et al.
Published: (1997-01-01)

The Role of TNF-α and Anti-TNF-α Agents during Preconception, Pregnancy, and Breastfeeding
by: Katarzyna Romanowska-Próchnicka, et al.
Published: (2021-03-01)

Tumor necrosis factor receptor 2 activation elicits sex-specific effects on cortical myelin proteins and functional recovery in a model of multiple sclerosis
by: Kayla L. Nguyen, et al.
Published: (2024-02-01)